It is tempting to speculate that the SphK1 activation upon chronic androgen deprivation may serve as an adaptive mechanism allowing prostate cancer cells to survive in androgen-depleted environment, as SphK1 is a well described pro-survival pathway via the effects of sphingosine 1-phosphate [27]. This evidence concerns the gene SPHK1 and Familial prostate cancer.